Brief: Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
12/05/2026 22:17
May 12 (Reuters) - Mirum Pharmaceuticals Inc MIRM.O: MIRUM PHARMACEUTICALS ANNOUNCES PROPOSED CONVERTIBLE SENIOR NOTES OFFERING MIRUM PHARMACEUTICALS INC - TO OFFER $600 MILLION CONVERTIBLE SENIOR NOTES DUE 2032 MIRUM PHARMACEUTICALS INC - INITIAL PURCHASERS MAY BUY UP TO $90 MILLION ADDITIONAL NOTES MIRUM PHARMACEUTICALS INC - NOTES TO MATURE ON JUNE 1, 2032 Source text: ID:nBw5SpLmla Further company coverage: MIRM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX